It indicates that in PAH due to CHD with the left-to-right shunt, rising flow in the pulmonary vasculature will stimulate physiologic responses such as higher levels of the vasoconstrictor endothelin-1 and vasodilators such as nitric oxide and prostacyclin as a counterbalance. The gene discussed is EDN1; the disease is pulmonary arterial hypertension.